6,266
Views
5
CrossRef citations to date
0
Altmetric
Drug Evaluation

Onasemnogene abeparvovec for the treatment of spinal muscular atrophy

ORCID Icon, , , , & ORCID Icon
Pages 1075-1090 | Received 12 Jan 2022, Accepted 12 Apr 2022, Published online: 02 May 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.